Skip to Content

Pressure BioSciences Inc PBIO Stock Quote

| Rating as of


Morningstar‘s Stock Analysis PBIO

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics PBIO

Company Profile PBIO

Business Description

Pressure BioSciences Inc is engaged in the healthcare division. It focuses on solving the problems inherent in biological sample preparation. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kit, MicroTubes, HUB High-Pressure Generators and Accessories, RF1700 Mini Ultra-High Pressure Pump, High-Pressure Cell Disruptors from Constant Systems, and SHREDDER Tubes, Service Contracts, and others.

14 Norfolk Avenue
South Easton, MA, 02375
T +1 508 230-1828
Industry Medical Devices
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 12